Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHalma Regulatory News (HLMA)

Share Price Information for Halma (HLMA)

Share Price is delayed by 15 minutes
Get Live Data
3,640.00    0.00 (0.00%)
Bid:
3,654.00
Ask:
3,658.00
Spread: 4.00 (0.109%)
Market Cap: £13.75b
HLMA Live PriceLast checked at - London Stock Exchange

Intraday Halma Share Chart

Acquisition

1 May 2024 07:00

RNS Number : 6925M
Halma PLC
01 May 2024
Β 

Halma plc ('Halma' or the 'Group')

Acquisition

Halma, the global group of life-saving technology companies, today announces that it has acquired MK Test Systems Limited (MK Test).

Founded in 1990 and headquartered in Wellington, Somerset, UK, MK Test designs and manufactures safety-critical electrical testing technology. Its products are used globally to test the integrity of high voltage electrical systems in aerospace, rail and commercial EV industries.

The cash consideration for MK Test is Β£44m, on a cash- and debt-free basis, to be funded from Halma's existing facilities. MK Test's unaudited revenue for the 12 months to March 2024 was Β£12.4m, with Return on Sales substantially above the upper end of Halma's target range of 18-22%. MK Test will be a standalone company within Halma's Safety sector, led by its current management team.

Marc Ronchetti, Group Chief Executive of Halma, commented:

"MK Test further enhances our capabilities in electrical safety and brings new opportunities for growth, driven by increasing safety regulation and the need to protect high value assets. Its technology plays an important role in automated electrical testing and in ensuring the integrity of electrical systems. We are delighted to welcome MK Test and to support its development as it continues to scale its business globally."

Jason Evans, Managing Director of MK Test, said:

"Passenger and operator safety is a top priority for our customers. They must ensure that platforms and machines with increasingly complex electrical systems are manufactured and assembled correctly, are operating within specification, and are being properly maintained. Joining Halma means we can grow our business in key markets while helping more businesses meet increasing safety regulations and demands for test traceability. MK Test Systems is aligned with Halma's purpose of growing a safer, cleaner, healthier future for everyone, every day."

For further information, please contact:

Halma plc

Marc Ronchetti, Group Chief Executive +44 (0)1494 721111

Steve Gunning, Group Chief Financial Officer

Melanie Horton, Deputy Head of Investor Relations +44 (0) 7554 013 396

Clayton Hirst, Director of Corporate Affairs +44 (0) 7384 796 013

MHP

Oliver Hughes / Rachel Farrington / Ollie Hoare +44 (0)20 3128 8100

A copy of this announcement, together with other information about Halma, is available at www.halma.com.

Β 

About Halma

Halma is a global group of life-saving technology companies, focused on growing a safer, cleaner, healthier future for everyone, every day. Its purpose defines the three broad markets it operates in:

Β· Safety - Protecting people's safety and the environment as populations grow, and enhancing worker safety.

Β· Environment - Addressing the impacts of climate change, pollution and waste, protecting life-critical resources and supporting scientific research.

Β· Health - Meeting the increasing demand for better healthcare as chronic illness rises, driven by growing and ageing populations and lifestyle changes.

It employs over 8,000 people in more than 20 countries, with major operations in theΒ UK, Mainland Europe, theΒ USAΒ andΒ Asia Pacific. Halma is listed on the London Stock Exchange (LON: HLMA) and is a constituent of the FTSE 100 index.

Halma has been named as one ofΒ Britain'sΒ Most Admired Companies for the past six years.

For more informationΒ www.halma.com

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
ACQIMMFTMTIJBMI
Date   Source Headline
21st Nov 20053:09 pmRNSNotice of Results
9th Nov 20057:00 amRNSAcquisition
27th Oct 20057:00 amRNSTrading Statement
19th Oct 20052:39 pmRNSAdditional Listing
13th Oct 20052:50 pmRNSDirector Declaration
27th Sep 20059:17 amRNSDirector/PDMR Shareholding
23rd Sep 20053:13 pmRNSDirector/PDMR Shareholding
9th Sep 20054:41 pmRNSHolding(s) in Company
2nd Sep 20057:00 amRNSAdoption of IFRS
12th Aug 20059:32 amRNSDirector/PDMR Shareholding
11th Aug 20059:15 amRNSAcquisition
10th Aug 20053:23 pmRNSDirector/PDMR Shareholding
9th Aug 20052:30 pmRNSDirector/PDMR Shareholding
5th Aug 200512:44 pmRNSResult of AGM
3rd Aug 20057:00 amRNSAGM Statement
29th Jul 20054:53 pmRNSBlocklisting Interim Review
27th Jul 200511:11 amRNSHolding(s) in Company
22nd Jul 20054:05 pmRNSAnnual Information Update
19th Jul 20051:24 pmRNSAcquisition
12th Jul 20054:16 pmRNSDirector/PDMR Shareholding
12th Jul 20052:55 pmRNSHolding(s) in Company
6th Jul 20054:37 pmRNSDirector/PDMR Shareholding
5th Jul 20055:16 pmRNSAnnual Report and Accounts
1st Jul 20054:45 pmRNSHolding(s) in Company
29th Jun 20059:56 amRNSDirector Shareholding
24th Jun 20054:53 pmRNSDirector Shareholding
21st Jun 20057:00 amRNSFinal Results
6th Jun 20059:51 amRNSNotice of Board Meeting
28th Apr 20057:00 amRNSTrading Statement
1st Mar 20057:00 amRNSDirectorate Change
8th Feb 200510:15 amRNSDirector Shareholding
17th Jan 20059:30 amRNSBlocklisting Interim Review
17th Jan 20059:26 amRNSDirector Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.